- Home
- ASB vs XENE Comparison
ASB vs XENE Comparison
Compare ASB & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ASB | XENE |
|---|---|---|
| Founded | 1861 | 1996 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7B | 5.7B |
| IPO Year | 2014 | 2014 |
Fundamental Metrics
Financial Performance| Metric | ASB | XENE |
|---|---|---|
| Price | $29.60 | $39.59 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 11 |
| Target Price | $29.75 | ★ $68.55 |
| AVG Volume (30 Days) | ★ 1.7M | 589.1K |
| Earning Date | 04-23-2026 | 05-08-2026 |
| Dividend Yield | ★ 3.45% | N/A |
| EPS Growth | ★ 284.72 | N/A |
| EPS | ★ 1.33 | N/A |
| Revenue | ★ $1,102,756,000.00 | $311,000.00 |
| Revenue This Year | $21.24 | N/A |
| Revenue Next Year | $8.86 | $2,496.48 |
| P/E Ratio | $22.47 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $23.86 | $35.97 |
| 52 Week High | $32.46 | $72.66 |
Technical Indicators
Market Signals| Indicator | ASB | XENE |
|---|---|---|
| Relative Strength Index (RSI) | 38.27 | 14.04 |
| Support Level | $27.03 | N/A |
| Resistance Level | $29.96 | $45.39 |
| Average True Range (ATR) | 0.59 | 1.80 |
| MACD | -0.09 | -1.31 |
| Stochastic Oscillator | 22.49 | 2.10 |
Price Performance
Historical ComparisonAbout ASB Associated Banc-Corp
Associated Banc-Corp is a bank holding company based in the United States of America. The company, through its subsidiaries, provides a broad array of banking and non-banking products and services to individuals and businesses. The group operates in three reportable segments: Corporate and Commercial Specialty; Community, Consumer, and Business; and Risk Management and Shared Services. The majority of its revenue is derived from the Corporate and Commercial Specialty segment, which serves a wide range of customers, including larger businesses, developers, not-for-profits, municipalities, and financial institutions by providing lending and deposit solutions as well as support to deliver, fund, and manage such banking solutions.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.